Follow
Kumaran Dandapani
Kumaran Dandapani
Director, In Vivo Pharmacology, Aragen Life Sciences
Verified email at aragen.com
Title
Cited by
Cited by
Year
Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats
D Kumaran, M Udayabanu, M Kumar, R Aneja, A Katyal
Neuroscience 155 (3), 626-639, 2008
972008
Inhibition of AAK1 kinase as a novel therapeutic approach to treat neuropathic pain
W Kostich, BD Hamman, YW Li, S Naidu, K Dandapani, J Feng, A Easton, ...
Journal of Pharmacology and Experimental Therapeutics 358 (3), 371-386, 2016
912016
Nitric oxide associated with iNOS expression inhibits acetylcholinesterase activity and induces memory impairment during acute hypobaric hypoxia
M Udayabanu, D Kumaran, RU Nair, P Srinivas, N Bhagat, R Aneja, ...
Brain research 1230, 138-149, 2008
902008
Benzamide protects delayed neuronal death and behavioural impairment in a mouse model of global cerebral ischemia
D Kumaran, M Udayabanu, RU Nair, R Aneja, A Katyal
Behavioural brain research 192 (2), 178-184, 2008
562008
Effect of losartan and enalapril on cognitive deficit caused by Goldblatt induced hypertension
RM Srinivasan J, Jayadev S, Kumaran D, Ahamed KF, Suresh B
Indian J Exp Biol. 43 (3), 241-246, 2008
39*2008
Effect of Ca2EDTA on Zinc Mediated Inflammation and Neuronal Apoptosis in Hippocampus of an In Vivo Mouse Model of Hypobaric Hypoxia
U Malairaman, K Dandapani, A Katyal
PLoS One 9 (10), e110253, 2014
382014
Free chelatable zinc modulates the cholinergic function during hypobaric hypoxia-induced neuronal damage: an in vivo study
M Udayabanu, D Kumaran, A Katyal
Neuroscience 202, 434-445, 2012
212012
Discovery of (S)-1-((2′,6-Bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable …
G Luo, L Chen, WA Kostich, B Hamman, J Allen, A Easton, C Bourin, ...
Journal of Medicinal Chemistry 65 (6), 4457-4480, 2022
142022
Discovery and optimization of biaryl alkyl ethers as a novel class of highly selective, CNS-penetrable, and orally active adaptor protein-2-associated kinase 1 (AAK1 …
G Luo, L Chen, WA Kostich, B Hamman, J Allen, A Easton, C Bourin, ...
Journal of Medicinal Chemistry 65 (6), 4534-4564, 2022
122022
Discovery, Structure–Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the …
RA Hartz, VT Ahuja, SJ Nara, CMV Kumar, JM Brown, LJ Bristow, ...
Journal of Medicinal Chemistry 64 (15), 11090-11128, 2021
122021
[3H] BMT-046091 a potent and selective radioligand to determine AAK1 distribution and target engagement
JV Louis, Y Lu, R Pieschl, Y Tian, Y Hong, K Dandapani, S Naidu, ...
Neuropharmacology 118, 167-174, 2017
72017
Quinazoline and quinoline derivatives as inhibitors of adaptor associated kinase 1
R Hartz, V Ahuja, C Dzierba, B Dasgupta, W Kostich, S Nara, A Easton, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 252, 2016
2016
Discovery of brain penetrant adaptor associated kinase (AAK1) inhibitors as a potential novel treatment for neuropathic pain
R Hartz, V Ahuja, C Dzierba, W Kostich, S Nara, CM Vijayakumar, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 250, 2015
2015
Behavioural dysfunction and delayed neuronal death associated with cholinergic hypofunction during global cerebral ischemia and the effect of rivastigmine, galantamine and choline
A Katyal, D Kumaran, M Udayabanu
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE 30 (8), 670-670, 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–14